loading...| Preferred Name | risedronate sodium | |
| Synonyms |
Risedronate RISE monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate hemipentahydrate NE-58095 Actonel |
|
| Definitions |
The hemipentahydrate monosodium salt of risedronic acid, a synthetic pyridinyl bisphosphonate. Risedronic acid binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1528" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1528" NCI Thesaurus) |
|
| ID |
http://purl.bioontology.org/ontology/PDQ/CDR0000256445 |
|
| altLabel |
Risedronate RISE monosodium (1-hydroxy-2-(3-pyridinyl)ethylidene)bisphosphonate hemipentahydrate NE-58095 Actonel |
|
| CAS Registry |
115436-72-1 |
|
| Component of | ||
| cui |
C0166025 C1996201 C0246719 C0068472 |
|
| Date last modified |
2008-05-22 |
|
| definition |
The hemipentahydrate monosodium salt of risedronic acid, a synthetic pyridinyl bisphosphonate. Risedronic acid binds to hydroxyapatite crystals in bone and inhibits osteoclast-dependent bone resorption. Check for "https://www.cancer.gov/about-cancer/treatment/clinical-trials/intervention/C1528" active clinical trials using this agent. ("http://ncit.nci.nih.gov/ncitbrowser/ConceptReport.jsp?dictionary=NCI%20Thesaurus&code=C1528" NCI Thesaurus) |
|
| Legacy PDQ ID |
11395 |
|
| LT |
TRD |
|
| NCI ID |
C1528 |
|
| notation |
CDR0000256445 |
|
| ORIG STY |
Drug/agent |
|
| prefLabel |
risedronate sodium |
|
| tui |
T109 T121 |